PUBLISHED WORKS
August 2016
Bardoxolone methyl prevents obesity and hypothalamic dysfunction
Camer D et al. Chem Biol Interact 2016;256:178-87.
June 2015
Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory
Camer D et al. Prog Neuropsychopharmacol Biol Psychiatry 2015;59:68-75.
September 2014
Comment on: Oleanolic acid co-administration alleviates ethanol-induced hepatic injury via Nrf-2 and ethanol-metabolizing modulation (sic) in rats
Camer D et al. Chem Biol Interact 2014;223:116.
January 2016
Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet
Camer D et al. Chem Biol Interact 2016;243:10-8.
March 2015
Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?
Camer D et al. J Card Fail 2015;21(3):258-9.
April 2014
The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications
Camer D et al. Mol Nut Food Res 2014;58(8):1750-9.
September 2015
Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet
Camer D et al. Mol Cell Endocrinol 2015;412:36-43.
October 2014
The endothelin pathway: a protective or detrimental target of bardoxolone methyl on cardiac function in patients with advanced chronic kidney disease?
Camer D et al. Am J Nephrol 2014;40(3):288-90.
CO-AUTHORED PUBLICATIONS
-
Feng Y, Yu Y, Wang S, Ren J, Camer D et al. Pharm Biol 2016;54(6):1027-34.
-
Dinh HL C, Szabo A, Yu Y, Camer D et al. ScientificWorldJournal 2015;2015:549352.
-
Dinh HL C, Szabo A, Yu Y, Camer D et al. Nutrients 2015;7(6):4705-23.
-
Cusick A, Camer D et al. Journal of Peer Learning 2015;8:18-33.
-
Cheng L, Yu Y, Szabo A, Wu Y, Wang H, Camer D et al. J Nut Biochem 2015;26(5):541-8.
-
Dinh HL C, Szabo A, Camer D et al. Chem Biol Interact 2015;229:1-8.